Drug intelligence / Profile preview

clomipramine + nortriptyline

Development stage
Unknown
Modality
Small Molecules
Administration
Oral, Intramuscular
01

Overview

Clomipramine + nortriptyline is a combination of two tricyclic antidepressants, clomipramine and nortriptyline. Both drugs act primarily by inhibiting the reuptake of serotonin and norepinephrine at neuronal synapses, thereby increasing their levels in the brain. Clomipramine is a strong serotonin reuptake inhibitor with additional effects on norepinephrine reuptake via its active metabolite, while nortriptyline preferentially inhibits norepinephrine reuptake but also affects serotonin. This combination has been studied for use in obsessive-compulsive disorder (OCD), where it demonstrated greater efficacy than clomipramine alone, possibly due to synergistic enhancement of both serotonergic and noradrenergic neurotransmission[1][2][8]. Both agents also have anticholinergic properties and can block other receptors such as histamine H1 and adrenergic receptors.

02

Targets

HRH1 (Histamine H1 Receptor)ADRB1 (β1)HTR2A (Serotonin receptor 5-HT2A)ADRA1A (α1A)NET (Norepinephrine Transporter)mAChR (Muscarinic acetylcholine receptors)SERT (Sodium-dependent serotonin transporter)

Beyond the preview

Go deeper on clomipramine + nortriptyline.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on clomipramine + nortriptyline.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call